U.S. Physical Therapy, Inc. to Issue Quarterly Dividend of $0.46 (NYSE:USPH)

U.S. Physical Therapy, Inc. (NYSE:USPHGet Free Report) declared a quarterly dividend on Wednesday, August 5th. Stockholders of record on Friday, August 21st will be paid a dividend of 0.46 per share on Friday, September 11th. This represents a c) annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Friday, August 21st.

U.S. Physical Therapy has increased its dividend by an average of 0.4%per year over the last three years and has increased its dividend every year for the last 6 years. U.S. Physical Therapy has a dividend payout ratio of 62.4% meaning its dividend is sufficiently covered by earnings. Equities analysts expect U.S. Physical Therapy to earn $3.46 per share next year, which means the company should continue to be able to cover its $1.84 annual dividend with an expected future payout ratio of 53.2%.

U.S. Physical Therapy Trading Up 1.9%

Shares of USPH stock opened at $77.33 on Thursday. The business’s fifty day moving average is $69.62 and its 200 day moving average is $74.26. The company has a market capitalization of $1.18 billion, a PE ratio of 154.67, a price-to-earnings-growth ratio of 2.10 and a beta of 1.13. U.S. Physical Therapy has a 52-week low of $58.19 and a 52-week high of $93.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.19 and a current ratio of 1.19.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.75 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The firm had revenue of $214.06 million for the quarter, compared to analysts’ expectations of $211.36 million. During the same period in the prior year, the business posted $0.81 earnings per share. The business’s quarterly revenue was up 8.5% on a year-over-year basis. On average, equities research analysts anticipate that U.S. Physical Therapy will post 2.99 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

USPH has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. Zacks Research upgraded U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Citizens Jmp restated a “market outperform” rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Friday, July 24th. Finally, Barrington Research reduced their price target on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $97.50.

View Our Latest Stock Analysis on U.S. Physical Therapy

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

See Also

Dividend History for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.